Sphingosine Kinase 1 Is Required for Mesothelioma Cell Proliferation: Role of Histone Acetylation

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Kalari, Satish ^a   Moolky, Nagabhushan ^b   Pendyala, Srikanth ^b   Berdyshev, Evgeny V ^b   Rolle, Cleo ^c   Kanteti, Rajani ^c   Kanteti, Archana ^b   Ma, Wenli ^b   He, Donghong ^b   Husain, Aliya N ^d   Kindler, Hedy L ^c   Kanteti, Prasad ^b   Salgia, Ravi ^c   Natarajan, Viswanathan ^b  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c SECTION OF HEMATOLOGY ONCOLOGY   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (4 HYDROXYANILINO) 4 (4 CHLOROPHENYL)THIAZOLE; ANACARDIC ACID; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; HISTONE ACETYLTRANSFERASE PCAF; MESSENGER RNA; PHOSPHOTRANSFERASE INHIBITOR; SPHINGOSINE KINASE 1; SPHINGOSINE KINASE 2; TRICHOSTATIN A; UNCLASSIFIED DRUG;

AKB GENE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CDK2 GENE; CELL LYSATE; CELL PROLIFERATION; CONTROLLED STUDY; DNA REPLICATION; DOWN REGULATION; GENE; GENE ACTIVATION; GRANULOMA; HAT1 GENE; HISTONE ACETYLATION; HUMAN; HUMAN TISSUE; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MESOTHELIUM CELL; MITOSIS SPINDLE; MOUSE; MYST2 GENE; NONHUMAN; PLEURA MESOTHELIOMA; PROTEIN EXPRESSION; TOP2A GENE; TRANSCRIPTION REGULATION; UPREGULATION; WILD TYPE;

ACETYLATION; ANIMALS; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; HISTONES; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; MESOTHELIOMA; MICE; MICE, INBRED C57BL; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); TANDEM MASS SPECTROMETRY;

MUS;

EID: 84866443065     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045330     Document Type: Article

References (60)

1. Campbell NP, Kindler HL, (2011) Update on Malignant Pleural Mesothelioma. Seminars in Respiratory and Critical Care Medicine 32: 102-110.
2. Paik PK, Krug LM, (2010) Histone deacetylase inhibitors in malignant pleural mesothelioma: preclinical rationale and clinical trials. J Thorac Oncol 5: 275-279.
3. Kim HJ, Bae SC, (2011) Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs. Am J Transl Res 3: 166-179.
4. Bots M, Johnstone RW, (2009) Rational combinations using HDAC inhibitors. Clin Cancer Res 15: 3970-3977.
5. Strub GM, Maceyka M, Hait NC, Milstein S, Spiegel S, (2010) Extracellular and intracellular actions of sphingosine-1-phosphate. Adv Exp Med Biol 688: 141-155.
6. Rapizzi E, Donati C, Cencetti F, Pinton P, Rizzuto R, et al. (2007) Sphingosine 1-phosphate receptors modulate intracellular Ca2+ homeostasis. Biochem Biophys Res Commun 353: 268-274.
7. Xia P, Wang L, Gamble JR, Vadas MA, (1999) Activation of sphingosine kinase by tumor necrosis factor-alpha inhibits apoptosis in human endothelial cells. J Biol Chem 274: 34499-34505.
8. Kwon YG, Min JK, Kim KM, Lee DJ, Billiar TR, et al. (2001) Sphingosine 1-phosphate protects human umbilical vein endothelial cells from serum-deprived apoptosis by nitric oxide production. J Biol Chem 276: 10627-10633.
9. Limaye V, Li X, Hahn C, Xia P, Berndt MC, et al. (2005) Sphingosine kinase-1 enhances endothelial cell survival through a PECAM-1-dependent activation of PI-3K/Akt and regulation of Bcl-2 family members. Blood 105: 3169-3177.
10. Zheng DM, Kitamura T, Ikejima K, Enomoto N, Yamashina S, et al. (2006) Sphingosine 1-phosphate protects rat liver sinusoidal endothelial cells from ethanol-induced apoptosis: Role of intracellular calcium and nitric oxide. Hepatology 44: 1278-1287.
11. Bonnaud S, Niaudet C, Pottier G, Gaugler MH, Millour J, al (2007) Sphingosine-1-phosphate protects proliferating endothelial cells from ceramide-induced apoptosis but not from DNA damage-induced mitotic death. Cancer Res 67: 1803-1811.
12. Moriue T, Igarashi J, Yoneda K, Nakai K, Kosaka H, et al. (2008) Sphingosine 1-phosphate attenuates H2O2-induced apoptosis in endothelial cells. Biochem Biophys Res Commun 368: 852-8527.
13. Berdyshev EV, Gorshkova I, Usatyuk P, Kalari S, Zhao Y, et al. (2011) Intracellular S1P generation is essential for S1P-induced motility of human lung endothelial cells: role of sphingosine kinase 1 and S1P lyase. PLoS One 6: e16571.
14. Pitson SM, Moretti PA, Zebol JR, Lynn HE, Xia P, al (2003) Activation of sphingosine kinase 1 by ERK1/2-mediated phosphorylation. EMBO J 22: 5491-5500.
15. Cuvillier O, (2008) Downregulating sphingosine kinase-1 for cancer therapy. Expert Opin Ther Targets 12: 1009-1020.
16. Cuvillier O, (2007) Sphingosine kinase-1-a potential therapeutic target in cancer. Anticancer Drugs 18: 105-110.
17. Shida D, Takabe K, Kapitonov D, Milstien S, Spiegel S, (2008) Targeting SphK1 as a new strategy against cancer. Curr Drug Targets 9: 662-673.
18. Billich A, Baumruker T, (2008) Sphingolipid metabolizing enzymes as novel therapeutic targets. Subcell Biochem 49: 413-420.
19. Nava VE, Hobson JP, Murthy S, Milstien S, Spiegel S, (2002) Sphingosine kinase type 1 promotes estrogen-dependent tumorigenesis of breast cancer MCF-7 cells. Exp Cell Res 281: 115-127.
20. Li J, Guan HY, Gong LY, Song LB, Zhang N, et al. (2008) Clinical significance of sphingosine kinase-1 expression in human astrocytoma progression and overall patient survival. Clin Cancer Res 14: 6996-7003.
21. Saddoughi SA, Song P, Ogretmen B, (2008) Roles of bioactive sphingolipids in cancer biology and therapeutics. Subcell Biochem 49: 413-440.
22. Huwiler A, Zangemeister-Wittke U, (2007) Targeting the conversion of ceramide to sphingosine 1-phosphate as a novel strategy for cancer therapy. Crit Rev Oncol Hematol 63: 150-159.
23. Vadas M, Xia P, McCaughan G, Gamble J, (2008) The role of sphingosine kinase 1 in cancer: oncogene or non-oncogene addiction? Biochim Biophys Acta 1781: 442-447.
24. Bonhoure E, Lauret A, Barnes DJ, Martin C, Malavaud B, et al. (2008) Sphingosine kinase-1 is a downstream regulator of imatinib-induced apoptosis in chronic myeloid leukemia cells. Leukemia 22: 971-979.
25. Johnson KR, Johnson KY, Crellin HG, Ogretmen B, Boylan AM, et al. (2005) Immunohistochemical distribution of sphingosine kinase 1 in normal and tumor lung tissue. J Histochem Cytochem 53: 1159-1166.
26. Martin JL, Lin MZ, McGowan EM, Baxter RC, (2009) Potential of growth factor signaling by insulin-like growth factor-binding protein-3 in breast epithelial cells requires sphingosine kinase activity. J Biol Chem 284: 25542-25552.
27. Liu H, Toman RE, Goparaju SK, Maceyka M, Nava VE, et al. (2003) Sphingosine kinase type 2 is a putative BH3-only protein that induces apoptosis. J Biol Chem 278: 40330-40336.
28. Hait NC, Sarkar S, Le Stunff H, Mikami A, Maceyka M, et al. (2005) Role of sphingosine kinase 2 in cell migration toward epidermal growth factor. J Biol Chem 280: 29462-29469.
29. Mackinnon AC, Tretiakova M, Henderson L, Mehta RG, Yan BC, et al. (2011) Paxillin expression and amplification in early lung lesions of high-risk patients, lung adenocarcinoma and metastatic disease. J Clin Pathol 64: 16-24.
30. Zhao Y, Kalari SK, Usatyuk PV, Gorshkova I, He D, et al. (2007) Intracellular generation of sphingosine 1-phosphate in human lung endothelial cells: role of lipid phosphate phosphatase-1 and sphingosine kinase 1. J Biol Chem 282: 14165-14177.
31. Berdyshev EV, Gorshkova IA, Garcia JG, Natarajan V, Hubbard WC, (2005) Quantitative analysis of sphingoid base-1-phosphates as bisacetylated derivatives by liquid chromatography-tandem mass spectrometry. Anal Biochem 339: 129-136.
32. Berdyshev EV, Gorshkova IA, Usatyuk P, Zhao Y, Saatian B, et al. (2006) De novo biosynthesis of dihydrosphingosine-1-phosphate by sphingosine kinase 1 in mammalian cells. Cell Signal 18: 1779-1792.
33. Poland CA, Duffin R, Kinloch I, Maynard A, Wallace WA, et al. (2008) Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat Nanotechnol 3: 423-428.
34. Riccio A, (2010) New endogenous regulators of class I histone deacetylases. SCI SIGNAL 3: 1-4.
35. Kang-Decker N, Tong C, Boussouar F, Baker DJ, Xu W, et al. (2004) Loss of CBP causes T cell lymphomagenesis in synergy with p27Kip1 insufficiency. Cancer Cell 5: 177-189.
36. Loganathan S, Kanteti R, Siddiqui SS, El-Hashani E, Tretiakova M, et al. (2011) Role of protein kinase C β and vascular endothelial growth factor receptor in malignant pleural mesothelioma: Therapeutic implications and the usefulness of Caenorhabditis elegans model organism. J Carcinog 10: 4-12.
37. Pogribny IP, Tryndyak VP, Muskhelishvili L, Rusyn I, Ross SA, (2007) Methyl deficiency, alterations in global histone modifications, and carcinogenesis. J Nutr 137: 216S-222S.
38. Pitson SM, Xia P, Leclercq TM, Moretti PA, Zebol JR, et al. (2005) Phosphorylation-dependent translocation of sphingosine kinase to the plasma membrane drives its oncogenic signaling. J Exp Med 201: 49-54.
39. Le Scolan E, Pchejetski D, Banno Y, Denis N, Mayeux P, et al. (2005) Overexpression of sphingosine kinase 1 is an oncogenic event in erythroleukemic progression. Blood 106: 1808-1816.
40. Sinha UK, Schorn VJ, Hochstim C, Chinn SB, Zhu S, et al. (2011) Increased radiation sensitivity of head and neck squamous cell carcinoma with sphingosine kinase 1 inhibition. Head Neck 33: 178-188.
41. Shirai K, Kaneshiro T, Wada M, Furuya H, Bielawski J, et al. (2011) A role of sphingosine kinase 1 in head and neck carcinogenesis. Cancer Prev Res (Phila) 4: 454-62.
42. Malavaud B, Pchejetski D, Mazerolles C, de Paiva GR, Calvet C, et al. (2010) Sphingosine kinase-1 activity and expression in human prostate cancer resection specimens. Eur J Cancer 46: 3417-3424.
43. Kawamori T, Kaneshiro T, Okumura M, Maalouf S, Uflacker A, et al. (2009) Role for sphingosine kinase 1 in colon carcinogenesis. FASEB J 23: 405-414.
44. Sukocheva O, Wang L, Verrier E, Vadas MA, Xia P, (2009) Restoring endocrine response in breast cancer cells by inhibition of the sphingosine kinase-1 signaling pathway. Endocrinology 150: 4484-4492.
45. Young N, Pearl DK, Van BrocklynJR, (2009) Sphingosine-1-phosphate regulates glioblastoma cell invasiveness through the urokinase plasminogen activator system and CCN1/Cyr61. Mol Cancer Res 7: 23-32.
46. Kapitonov D, Allegood JC, Mitchell C, Hait NC, Almenara JA, et al. (2009) Targeting sphingosine kinase 1 inhibits Akt signaling, induces apoptosis, and suppresses growth of human glioblastoma cells and xenografts. Cancer Res 69: 6915-6923.
47. Guan H, Song L, Cai J, Huang Y, Wu J, et al. (2011) Sphingosine Kinase 1 Regulates the Akt/FOXO3a/Bim Pathway and Contributes to Apoptosis Resistance in Glioma Cells. PLoS One 6: e19946.
48. Liu G, Zheng H, Zhang Z, Wu Z, Xiong H, et al. (2010) Overexpression of sphingosine kinase 1 is associated with salivary gland carcinoma progression and might be a novel predictive marker for adjuvant therapy. BMC Cancer 10: 495.
49. Song L, Xiong H, Li J, Liao W, Wang L, et al. (2011) Sphingosine kinase-1 enhances resistance to apoptosis through activation of PI3K/Akt/NF-κB pathway in human non-small cell lung cancer. Clin Cancer Res 17: 1839-1849.
50. Li W, Yu CP, Xia JT, Zhang L, Weng GX, et al. (2009) Sphingosine kinase 1 is associated with gastric cancer progression and poor survival of patients. Clin Cancer Res 15: 1393-1399.
51. Sankala HM, Hait NC, Paugh SW, Shida D, Lepine S, et al. (2007) Involvement of sphingosine kinase 2 in p53-independent induction of p21 by the chemotherapeutic drug doxorubicin. Cancer Res 67: 10466-10474.
52. Van BrocklynJR, Jackson CA, Pearl DK, Kotur MS, Snyder PJ, et al. (2005) Sphingosine kinase-1 expression correlates with poor survival of patients with glioblastoma multiforme: roles of sphingosine kinase isoforms in growth of glioblastoma cell lines. J Neuropathol Exp Neurol 64: 695-705.
53. Ghaemmaghami S, Huh WK, Bower K, Howson RW, Belle A, et al. (2003) Global analysis of protein expression in yeast. Nature 425: 738-741.
54. Gygi SP, Rochon Y, Franza BR, Aebersold R, (1999) Correlation between protein and mRNA abundance in yeast. Molecular Cell Biol 3: 1720-1730.
55. Vivo C, Lecomte C, Levy F, Leroy K, Kirova Y, et al. (2003) Cell cycle checkpoint status in human malignant mesothelioma cell lines: response to gamma radiation. BR J Cancer 88: 388-395.
56. Desdouets C, Bréchot C, (2000) p27: a pleiotropic regulator of cellular phenotype and a target for cell cycle dysregulation in cancer. Pathol Biol (Paris) 48: 203-210.
57. Waldman T, Kinzler KW, Vogelstein B, (1995) p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res 55: 5187-5190.
58. Turner BM, (1991) Histone acetylation and control of gene expression. J Cell Sci 99: 13-20.
59. Struhl K, (1998) Histone acetylation and transcriptional regulatory mechanisms. Genes Dev 12: 599-606.
60. Hait NC, Allegood J, Maceyka M, Strub GM, Harikumar KB, et al. (2009) Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate. Science 325: 1254-1257.